Browse > Article

Human immunodeficiency virus infection in the elderly  

Choe, Pyoeng-Gyun (Department of Internal Medicine, Seoul National University College of Medicine)
Kim, Nam-Joong (Department of Internal Medicine, Seoul National University College of Medicine)
Publication Information
The Korean Journal of Medicine / v.79, no.4, 2010 , pp. 356-361 More about this Journal
Abstract
The proportion of human immunodeficiency virus (HIV) infected patients aged 50 and older has greatly increased since the beginning of the epidemic, particularly after the introduction of combination antiretroviral therapy. In Korea, 25% of those infected with HIV were older than 50 in 2009. Older untreated patients with HIV demonstrate faster rates of CD4 lymphocyte loss and more rapid progression to acquired immunodeficiency syndrome and death than younger individuals. Most studies have shown that compared with younger patients, patients over 50 generally have a slower immunologic response to antiretroviral therapy, despite a better virological response. Management of HIV infection in older patients is particularly complex, mainly because they are more likely to have co-morbidities necessitating specific medications that may interact with antiretroviral drugs. Patients living longer with HIV are more likely to develop diseases associated with aging, and at an earlier age, than those without HIV. These include dementia, coronary artery disease, dyslipidemia, metabolic syndrome, diabetes, and osteoporosis.
Keywords
HIV; AIDS; Elderly; Aging;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Oh MD. Antiretroviral therapy for treatment of human immunodeficiency virus type 1 infection. J Korean Med Assoc 50:316-323, 2007   DOI   ScienceOn
2 Goetz MB, Boscardin WJ, Wiley D, Alkasspooles S. Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy. AIDS 15:1576-1579, 2001   DOI   ScienceOn
3 Gebo KA. HIV and aging: implications for patient management. Drugs Aging 23:897-913, 2006   DOI   ScienceOn
4 Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP Jr. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med 167:684-691, 2007   DOI   ScienceOn
5 Shah SS, McGowan JP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis 35:1238-1243, 2002   DOI   ScienceOn
6 Simone MJ, Appelbaum J. HIV in older adults. Geriatrics 63:6-12, 2008
7 Knobel H, Guelar A, Valldecillo G, Carmona A, Gonzalez A, Lopez-Colomes JL, Saballs P, Gimeno JL, Diez A. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS 15:1591-1593, 2001   DOI   ScienceOn
8 Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD. Effect of early versus deferred anti-retroviral therapy for HIV on survival. N Engl J Med 360:1815-1826, 2009   DOI   ScienceOn
9 Nolan L, O'Malley K. Prescribing for the elderly: part I. sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 36:142-149, 1988   DOI
10 Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years. Clin Infect Dis 45: 654-657, 2007   DOI   ScienceOn
11 Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 18(Suppl 1):S19-S25, 2004   DOI
12 Tumbarello M, Rabagliati R, De Gaetano Donati K, Bertagnolio S, Tamburrini E, Tacconelli E, Cauda R. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS 17:128-131, 2003   DOI   ScienceOn
13 Mussini C, Manzardo C, Johnson M, Monforte A, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miro JM, Sabin C. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis. AIDS 22:2461-2469, 2008   DOI   ScienceOn
14 Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo- controlled trial. N Engl J Med 317:185-191, 1987   DOI   ScienceOn
15 Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860, 1998   DOI   ScienceOn
16 Rhee MS, Greenblatt DJ. Pharmacologic consideration for the use of antiretroviral agents in the elderly. J Clin Pharmacol 48:1212-1225, 2008   DOI   ScienceOn
17 Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Response to combination antiretroviral therapy: variation by age. AIDS 22:1463-1473, 2008   DOI   ScienceOn
18 Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis 41:361-372, 2005   DOI   ScienceOn
19 Braithwaite RS, Roberts MS, Chang CC, Goetz MB, Gibert CL, Rodriguez-Barradas MC, Shechter S, Schaefer A, Nucifora K, Koppenhaver R, Justice AC. Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med 148:178-185, 2008   DOI   ScienceOn
20 Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 1July, 2010
21 Korea Centers for Disease Control. KCDC Public Health Weakly Report. Available at: http://www.cdc.go.kr/phwr. Accessed 1 July, 2010
22 Chiao EY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis 28:740-745, 1999   DOI   ScienceOn
23 El-Sadr W, Gettler J. Unrecognized human immunodeficiency virus infection in the elderly. Arch Intern Med 155:184-186, 1995   DOI   ScienceOn
24 Abel T, Werner M. HIV risk behaviour of older persons. Eur J Public Health 13:350-352, 2003   DOI   ScienceOn
25 Paul SM, Martin RM, Lu SE, Lin Y. Changing trends in human immunodeficiency virus and acquired immunodeficiency syndrome in the population aged 50 and older. J Am Geriatr Soc 55:1393-1397, 2007   DOI   ScienceOn
26 Skiest DJ, Keiser P. Human immunodeficiency virus infection in patients older than 50 years: a survey of primary care physicians' beliefs, practices, and knowledge. Arch Fam Med 6:289-294, 1997   DOI   ScienceOn
27 Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41:1-19, 1992
28 Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 355:1131-1137, 2000   DOI   ScienceOn
29 Phillips A, Pezzotti P. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 18:51-58, 2004   DOI   ScienceOn
30 Centers for Disease Control and Prevention. AIDS among persons aged > or=50 years: United States, 1991-1996. MMWR Morb Mortal Wkly Rep 47:21-27, 1998
31 Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372:293-299, 2008   DOI   ScienceOn
32 Mack KA, Ory MG. AIDS and older Americans at the end of the Twentieth Century. J Acquir Immune Defic Syndr 33(Suppl 2):S68-S75, 2003   DOI
33 Centers for Disease Control and Prevention. Epidemiology of HIV/AIDS: United States, 1981-2005. MMWR Morb Mortal Wkly Rep 55:589-592, 2006
34 Kirk JB, Goetz MB. Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc 57:2129-2138, 2009   DOI   ScienceOn
35 Grabar S, Weiss L, Costagliola D. HIV infection in older patients in the HAART era. J Antimicrob Chemother 57:4-7, 2006   DOI
36 Larussa D, Lorenzini P, Cingolani A, Bossolasco S, Grisetti S, Bongiovanni M, Moretti F, Uccella I, Zannoni P, Foresti S, Mazzarello G, Arcidiacono MI, Pedale R, Ammassari A, Tozzi V, Perno CF, Monforte AD, Cinque P, Antinori A. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retroviruses 22:386-392, 2006   DOI   ScienceOn
37 Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Moller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 371:1417-1426, 2008   DOI   ScienceOn
38 Sabin CA, Smith CJ, Delpech V, Anderson J, Bansi L, Gilson R, Schwenk A, Leen C, Gazzard B, Porter K, Mackie N, Fisher M, Orkin C, Johnson M, Easterbrook P, Hill T, Phillips AN. The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy. HIV Med 10:35-43, 2009
39 McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43:2245-2252, 1993   DOI   ScienceOn
40 Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63:822-827, 2004   DOI   ScienceOn
41 Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 118:e29-e35, 2008   DOI   ScienceOn
42 Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiebaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356:1723-1735, 2007   DOI   ScienceOn
43 Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18(Suppl 1):S11-S18, 2004
44 Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42:1472-1476, 1992   DOI
45 Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS 18 (Suppl 1):S27-S34, 2004
46 Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, Schwander S, Goebel FD, Glauser M, Antunes F. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 11:39-44, 1996   DOI   ScienceOn
47 Valcour V, Paul R. HIV infection and dementia in older adults. Clin Infect Dis 42:1449-1454, 2006   DOI   ScienceOn